Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease: An Analysis of Post RAISE.
Miyata K, Miura M, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H. Miyata K, et al. Among authors: matsushima t. Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007191. doi: 10.1161/CIRCOUTCOMES.120.007191. Epub 2021 Feb 5. Circ Cardiovasc Qual Outcomes. 2021. PMID: 33541111
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M; Post RAISE group. Miyata K, et al. Among authors: matsushima t. Lancet Child Adolesc Health. 2018 Dec;2(12):855-862. doi: 10.1016/S2352-4642(18)30293-1. Epub 2018 Oct 16. Lancet Child Adolesc Health. 2018. PMID: 30337183
Kawasaki Disease Initially Presenting as Cervical Lymphadenopathy.
Otani A, Iio K, Uda K, Matsushima T, Sakakibara H, Hataya H. Otani A, et al. Among authors: matsushima t. J Clin Rheumatol. 2021 Apr 1;27(3):e88-e89. doi: 10.1097/RHU.0000000000001263. J Clin Rheumatol. 2021. PMID: 31880603 No abstract available.
Clinical implications of gallbladder enlargement in Kawasaki disease.
Miyazawa A, Matsushima T, Sakakibara H, Akahoshi S, Morikawa Y, Koyama Y, Miyata K, Hataya H, Miura M. Miyazawa A, et al. Among authors: matsushima t. Pediatr Int. 2023 Jan-Dec;65(1):e15543. doi: 10.1111/ped.15543. Pediatr Int. 2023. PMID: 37493267
Methylprednisolone pulse and prednisolone for intensification of primary treatment in Kawasaki disease patients at high risk of treatment resistance: a multicenter prospective cohort study.
Miura M, Miyata K, Kaneko T, Akahoshi S, Morikawa Y, Matsushima T, Sakakibara H, Kobayashi T, Nakamura T, Takahashi T, Nakazawa M, Shibata A, Yamagishi H. Miura M, et al. Among authors: matsushima t. Eur J Pediatr. 2024 Oct;183(10):4265-4274. doi: 10.1007/s00431-024-05689-y. Epub 2024 Jul 25. Eur J Pediatr. 2024. PMID: 39048743
1,400 results